MYRIAD GENETICS INC
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
MYGN$5.67-1.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets as of December 31, 202 and
Consolidated Balance Sheets
(in millions, except per share amounts)
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $132.1 | $56.9 |
| Marketable investment securities | 8.8 | 58.0 |
| Trade accounts receivable | 114.3 | 101.6 |
| Inventory | 22.0 | 20.1 |
| Prepaid taxes | 17.0 | 17.6 |
| Prepaid expenses and other current assets | 19.4 | 20.4 |
| Total current assets | 313.6 | 274.6 |
| Operating lease right-of-use assets | 61.6 | 103.9 |
| Long-term marketable investment securities | — | 54.8 |
| Property, plant and equipment, net | 119.0 | 83.4 |
| Intangibles, net | 349.5 | 379.7 |
| Goodwill | 287.4 | 286.8 |
| Other assets | 15.4 | 15.5 |
| Total assets | $1,146.5 | $1,198.7 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $25.8 | $28.8 |
| Accrued liabilities | 113.9 | 94.3 |
| Current maturities of operating lease liabilities | 16.2 | 14.1 |
| Total current liabilities | 155.9 | 137.2 |
| Unrecognized tax benefits | 30.2 | 26.8 |
| Long-term debt | 38.5 | — |
| Noncurrent operating lease liabilities | 97.4 | 130.9 |
| Other long-term liabilities | 41.3 | 18.0 |
| Total liabilities | 363.3 | 312.9 |
| Commitments and contingencies | ||
| Stockholders’ equity: | ||
| Common stock, $0.01 par value, 89.9 and 81.2 shares outstanding at December 31, 2023 and 2022, respectively | 0.9 | 0.8 |
| Additional paid-in capital | 1,415.5 | 1,260.1 |
| Accumulated other comprehensive loss | (3.7) | (8.9) |
| Accumulated deficit | (629.5) | (366.2) |
| Total stockholders' equity | 783.2 | 885.8 |
| Total liabilities and stockholders’ equity | $1,146.5 | $1,198.7 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.